Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Published in M2 EquityBites on Tuesday, 30 October 2007
Reply New Message
Prev Message Back To Forum Threaded View Next Message
22 million was offered and refused pre-markman.... the min is 22 million... Have the stepped up the prices.... my guess was yes... with the delay of signings...
1 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply